PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

The Future

  1. 319 Posts.
    lightbulb Created with Sketch. 57
    I have just finished Loading up on this stock and had to post about my excitement for it's potential. I work in an associated field and people are constantly asking about the option of injectable therapy for Arthritis. It make intuitive sense to people, especially farmers, tradies etc that something can be put into a joint and improve their function and pain. Although Pentosan isn't a product that involves simple things like shock absorption or direct analgesia/numbing of pain that people can simply understand it still will be very appealing to those who have arthritis who think along those lines. Joint arthroplasty/fusion/debridement/lavage are all unsatisfactory to so many patients and there are already proven business models of injectables for Arthritis using everything from steroids, patient sourced blood products, synthetic glycosaminoglycans among others that are (looking at recent results) little better than placebo and very unlikely to be looked upon favourably in comparison to Pentosan in the coming years.

    Can't wait for what the future holds
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.